The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination ibrutinib (Ibr) and venetoclax (Ven) for the treatment of mantle cell lymphoma (MCL): Primary endpoint assessment of the phase 2 AIM study.
 
Constantine Si Lun Tam
Honoraria - Abbvie; Janssen
Research Funding - Abbvie (Inst); Janssen (Inst)
 
Andrew Warwick Roberts
Research Funding - AbbVie (Inst); BeiGene (Inst); Janssen (Inst); Merck (Inst); Servier (Inst)
 
Mary Ann Anderson
No Relationships to Disclose
 
Sarah-Jane Dawson
No Relationships to Disclose
 
Rodney J Hicks
No Relationships to Disclose
 
Kate Burbury
No Relationships to Disclose
 
Gillian Turner
No Relationships to Disclose
 
Juliana Di Iulio
No Relationships to Disclose
 
Mathias Bressel
No Relationships to Disclose
 
David A. Westerman
No Relationships to Disclose
 
Rishu Agarwal
No Relationships to Disclose
 
Christiane Pott
No Relationships to Disclose
 
Martin H. Dreyling
No Relationships to Disclose
 
Mark A Dawson
No Relationships to Disclose
 
John Francis Seymour
Honoraria - Abbvie; Janssen